Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Droplette

Explore full profile

Needle-free and hand-held device that delivers large molecules deep through skin

Boston, United StatesFounded 2017Health Tech & Medtech
Valuation $50–100M Last recorded · 2021
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Droplette and the history behind them.

About Droplette

Droplette, a Boston-based company founded in 2017, operates at the intersection of medical science and consumer skincare. The company was established by two MIT-trained chemical engineers, Madhavi Gavini and Rathi Srinivas. Their journey began after attending a medical conference where they learned about epidermolysis bullosa (EB), a rare and painful genetic skin disease that primarily affects children. Motivated to find a painless method to deliver medication through the skin, they began experimenting with fluid physics, initially working with components purchased from eBay at Gavini's kitchen table. This research led to a breakthrough in transdermal delivery, which garnered early grant funding from NASA and the National Institutes of Health (NIH).

The core of Droplette's business is a smart device that transforms proprietary skincare serums into a high-velocity micro-mist. This technology, leveraging principles like fluid dynamics and the piezoelectric effect, creates droplets thousands of times smaller than traditional misters, allowing them to penetrate the skin's barrier up to 20 cell layers deep. This process enhances the efficacy of active ingredients, which often struggle to be absorbed when applied topically. The company's business model revolves around selling the handheld device and a subscription-based service for its single-use capsules containing various formulations. These capsules are formulated with dermatologist-recommended ingredients such as collagen, retinol, and glycolic acid to address concerns like hydration, fine lines, and blemishes.

The company's target market is the at-home consumer seeking clinical-grade skincare results without invasive procedures. Revenue is generated from the initial sale of the device and recurring monthly subscriptions for the serum capsules. Droplette has successfully raised significant capital to fuel its growth, including a Series B round that brought its total funding to over $39.5 million. Key investors include Spark Capital, Victress Capital, and Bolt. The company launched its second-generation device, Droplette 2, in 2023, featuring hardware and software upgrades, and a more integrated mobile app that allows users to connect with licensed estheticians for personalized guidance.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2017
Headquarters
Boston, United States
Employees
18
Open positions
None listed
Dealroom signal
58.9/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Risk Management, Oncology, Dermatology, Non-Invasive medical devices and treatments, Disease, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2b

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Dec 2021 $15M $62M Spark Capital · Amplifyher Ventures · Victress Capital · Bolt Innovation Group ↗
SEEDEquity / VC Mar 2019 $0 — Undisclosed —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Droplette website traffic

Latest recorded traffic for Droplette is 0 monthly website visits. Droplette's team declined 21.7% over the past year.

Latest monthly visits0 1-year team growth-21.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • MassChallenge

Series A4 investors entered at this stage

  • Spark Capital
  • Victress Capital
  • Amplifyher Ventures
  • Bolt Innovation Group

Other known investors4 additional known investors

Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States92.3%
🇪🇸 Spain7.7%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Droplette on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Droplette’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.